We sought to determine whether velocity vector imaging (VVI)-derived left ventricular (LV) myocardial deformation indices could detect subtle myocardial abnormalities in acute Kawasaki disease (KD).
Introduction
Kawasaki disease (KD) is an acute vasculitis of unknown aetiology and the leading cause of acquired heart disease in children in the USA. 1 The highest morbidity and mortality is associated with the development of coronary artery aneurysms during the subacute phase, which occurs in 20% of untreated KD patients. 2, 3 Treatment with intravenous immunoglobulin (IVIG) within 10 days of onset of fever decreases the risk for development of coronary artery aneurysms to 5%. 4, 5 Despite 40 years of research, there is no diagnostic test for KD. The epidemiological definition of the disease requires the child to exhibit fever for at least 5 days plus four of five characteristic physical findings. 3 In cases of KD where the child does not develop a sufficient number of physical findings, delays in diagnosis are associated with an increased risk of coronary artery aneurysms and associated morbidity. 4 To assist in the diagnosis of atypical or incomplete forms of KD, an algorithm was proposed by the American Heart Association (AHA) guiding the evaluation of patients with some but not all of the diagnostic criteria. This algorithm includes the performance of an echocardiogram in select cases. An echocardiogram is considered positive in this algorithm if there are coronary changes (dilation or aneurysm) or if three or more other features are present, including perivascular brightness, lack of coronary tapering, decreased left ventricular (LV) function, mitral regurgitation, pericardial effusion, or mild coronary artery dilation (CAD). 6 Although myocardial inflammation is universal in KD, the routine echocardiographic measurements of LV systolic function are often normal, limiting their usefulness in the algorithm. 7, 8 Velocity vector imaging (VVI; Siemens Medical Solutions USA, Inc., Mountain View, CA, USA) is a novel image analysis method that allows for the quantitative assessment of regional and global myocardial function, particularly for systolic function of the LV. 9, 10 We hypothesized that, in KD patients, despite normal LV systolic function measured by two-dimensional (2D) shortening fraction (SF) and ejection fraction (EF), VVI-derived indices of global and regional LV deformation will be abnormal. The purpose of this study was to evaluate the role of VVI-derived global and regional LV myocardial deformation in the detection of myocardial involvement in acute KD.
Methods

Study population
The Paediatric Cardiology database (2002 -2011) at Primary Children's Medical Center was reviewed to identify consecutive patients with KD.
Patients with incomplete KD and those with delayed treatment (.10 fever days) were excluded. Echocardiograms obtained at KD diagnosis were reviewed to include only those with adequate imaging of the LV myocardium and coronary arteries. Treatment resistance was defined as persistent or recrudescent fever .36 h after the completion of IVIG infusion (2 g/kg). 6 The control population consisted of age-matched children who underwent echocardiography for murmur evaluation and were found to have no cardiac abnormalities. This retrospective study was approved by the Institutional Review Board with a waiver of consent.
Echocardiogram and VVI
VVI (Siemens Medical Solutions USA, Inc.) is an angle-independent myocardial deformation imaging technique that calculates tissue velocity, strain (tissue deformation, 1), and strain rate (rate of tissue deformation, SR) using speckle tracking from digitally acquired routine 2D greyscale images. 9, 11 Over the duration of one R -R interval, VVI combines speckle tracking with other reference points to calculate myocardial velocities using Fourier analysis, allowing the derivation of 1 and SR data. VVI was performed on 2D echocardiographic images digitally obtained on KD patients and on the normal controls. Peak and average systolic longitudinal velocity, 1, and SR were measured by manually tracing the LV endocardial border in diastole by a single investigator (R.T.M.) from the apical four-chamber view using dedicated software (Syngo US; Siemens Medical Solutions USA, Inc.). Similarly, circumferential velocity, 1, and SR were measured by tracing the LV endocardial border in diastole from the parasternal short-axis view. Regional longitudinal myocardial deformation was evaluated from apical four-chamber images by dividing the LV into six segments: three on the LV free wall and three on the septum (base, middle, and apical for each). Regional circumferential myocardial deformation was evaluated by similarly dividing the LV into six segments in the short axis.
The coronary arteries were classified as dilated if the internal luminal diameter of the right coronary artery or left anterior descending coronary artery had a Z-score of .2.5. 
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Clinical data
The medical records were reviewed for clinical data, including initial history and physical examination findings, days of fever, and laboratory measurements of acute phase reactants (C-reactive protein, erythrocyte sedimentation rate, and albumin).
Statistical analysis
Comparisons were made between controls and (i) the entire KD group, (ii) KD group subdivided by CAD, and (iii) KD group subdivided by treatment resistance. For the descriptive summaries in Tables 1 and  2 , between-group comparisons on continuous data were performed using ANOVA. Categorical data were compared using the x 2 test. Statistical significance was defined as a P-value ,0.05. For unplanned comparisons, a Bonferroni adjustment was made. Each measurement was repeated for the six heart segments within each subject, therefore, a repeated measures analysis of variance was used to test the effect of KD on echocardiogram measurements. An unstructured covariance matrix was used to model the correlation of the segment measurements within each subject. Gender and body surface area were also included in the model and means are adjusted for these effects. Separate analyses using the same methods were performed on the KD subgroups. All comparisons are to the control group.
The mean echocardiogram measurements were tabulated after adjusting for gender and body surface area. Only pre-planned comparisons of KD and KD subgroups with controls were performed, so a multiple comparison adjustment to the significance level was not warranted. The repeated measures ANOVA were performed in Proc Mixed using SAS software version 9.3 (&2011, SAS Institute).
Results
Patient population
The KD (n ¼ 32) and control groups (n ¼ 22) were similar in age, weight, and gender ( Table 1 ). The KD group was predominantly Caucasian (80%), with a small percentage of Hispanic (12%) and other (6%). Overall, the KD subgroups were similar to the controls, although those with KD and CAD were more likely male (82 vs. 55%, P ¼ 0.04), and those with KD and normal coronary arteries weighed slightly more than controls (13.4 vs. 10.5 kg, P ¼ 0.05). All KD patients were treated within 10 fever days, with a mean of 5.8 + 1.8 days of fever prior to IVIG. All laboratory values were measured within 24 h of the echocardiogram. The laboratory values in the KD subgroups are provided in Table 2 .
Echocardiographic findings
Of the 32 echocardiograms in the KD group, 31 were performed prior to IVIG therapy and 1 was performed within 12 h of completion of IVIG infusion. The EF measurements were similar between the KD and control groups ( Table 1) . Although the SF was lower in the KD group compared with controls [36% (CI: 34-37) vs. 39% (CI: 37-41)], all SF values were within normal range for age.
The longitudinal regional and global VVI analysis is shown in Table 3 . Compared with controls, KD patients had lower global longitudinal 1 (215.29 vs. 212.94, P ¼ 0.04) and SR (21.12 vs. 20.87, P ¼ 0.003; Figure 1 ). When KD patients were subdivided into those with and those without CAD and compared with normal controls, only KD patients with CAD (n ¼ 17) had lower longitudinal 1 (215.29 vs. 211.87, P ¼ 0.02), but SR was lower in both those with and without CAD (21.12 vs. 20.86, P ¼ 0.005; and vs. 20.88, P ¼ 0.04, respectively). When the entire KD group was subdivided by treatment resistance, only those with resistant KD (n ¼ 14) had lower 1 compared with controls (215.29 vs. 211.8, P ¼ 0.01), but SR was lower for both resistant and non-resistant KD (21.12 vs. 20.82, P ¼ 0.003; and vs. 20.9, P ¼ 0.03, respectively). KD patients and subgroups had significantly lower myocardial longitudinal velocities compared with controls (Table 3; Figure 1 ). Longitudinal mean velocities, 1, and SR by segments are shown in Figure 2 for There was no statistically significant relationship between the degree of derangements in the laboratory values, including the degree of systemic inflammation as measured by CRP and VVIderived myocardial deformation indices.
Discussion
Myocardial involvement in KD has been well described and the characteristic abnormal histology appears universal for the disease. 13, 14 KD patients typically undergo echocardiographic measurements of SF and EF to evaluate their myocardial function. Although the AHA algorithm designed to improve early diagnosis for incomplete cases of KD uses echocardiographic evidence of decreased systolic function as supporting criteria, SF and EF are frequently normal and unable to detect subtle abnormalities of myocardial inflammation in KD. Some investigators demonstrated abnormal contractility on pre-treatment echocardiograms using stress -velocity index, but these methods require complicated analyses and are cumbersome to perform, limiting their widespread use. 15 Using VVI, our study demonstrates abnormal myocardial contractility with decreased 1 and SR, despite normal SF and EF. Unlike the stress -velocity index, VVI is simple, angle independent, and utilizes standard images but does require adequate imaging of the myocardium for tracing purposes. From previous studies, intra-observer variability and inter-observer variability have been found to be low at 3.6 -5.3% and 7 -11.8%, respectively. 16, 17 In our predominantly Caucasian population, longitudinal 1 and SR and circumferential 1 were decreased in patients with KD compared with controls. Strain and SR imaging may be a more sensitive indicator of myocardial involvement in KD. This is consistent with other studies where strain imaging has been shown to be useful in the early detection of myocardial involvement in asymptomatic patients with diabetes, systemic sclerosis, amyloidosis, and doxorubicin-induced cardiomyopathy. 18 -22 Knowledge of its use in evaluating myocardial function in KD has been limited. South Korean investigators showed abnormally decreased LV longitudinal 1 but normal SR by 2D imaging in children with acute KD. 23 Others have reported myocardial diastolic dysfunction using Doppler-derived strain in children following KD, but these investigators did not report changes in systolic measurements of strain. 24 In subgroup analyses, compared with controls, both longitudinal and circumferential 1 were decreased in the groups with CAD and/ or treatment resistance, but not in KD patients without CAD or in patients without treatment resistance. However, compared with each other, there was no difference in 1 in KD patients with vs. without CAD or in KD patients with vs. without treatment resistance. Further investigation in a larger cohort of patients is needed to determine whether VVI-derived 1 and SR can be used for risk stratification in KD.
Although there was a statistically significant difference in SF between the KD and control group, the SF measurements were within normal limits and its clinical utility in KD diagnosis in individual patients is limited. Circumferential 1, a measure of myocardial thickening from the parasternal short-axis view, was lower in KD subgroups of CAD and treatment resistance compared with controls. There was a more pronounced difference in longitudinal 1 and SR between KD groups and controls, although EF was similar between groups. Reduced LV myocardial deformation in the long axis measured by longitudinal 1 and SR thus may be a more robust indicator of myocardial involvement in KD.
This preliminary study has several limitations. The study is limited by its retrospective design in a small population. KD patients with 2D echo images inadequate for VVI analysis had to be excluded in order to avoid using equivocal images. While VVI has the advantage of being angle-independent and can be performed on routinely obtained 2D echocardiographic images, this method requires optimal image quality. VVI was able to be obtained only from the four-chamber view, as two-and three-chamber views were not routinely obtained during the study time period. Overlapping 1 and SR values between KD and normal patients in this relatively small study makes it difficult to derive a cut-off value for KD diagnosis. Varying 1 and SR values obtained by software from different vendor platform limits the ability to generalize the study results. Direction for future studies includes collaboration with multiple institutions to include a larger paediatric population, with prospective data collection to increase the number of echo studies suitable for strain analysis. In the future, it would also be informative to look at changes in 1 and SR over time with recovery from KD, which was unfortunately not possible in this study due to incomplete followup at this tertiary care centre.
Conclusion
Despite normal systolic LV function by routine echo measures, KD patients have reduced longitudinal 1 and SR, which may be more sensitive indicators of myocardial inflammation. If these findings are supported in larger studies, adding 1 and SR to the echo evaluation may provide supportive criteria to decrease delayed diagnosis of KD. 
